-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Overweight on HCA Healthcare, Lowers Price Target to $496

Benzinga·04/27/2026 15:05:41
Listen to the news
Barclays analyst Andrew Mok maintains HCA Healthcare (NYSE:HCA) with a Overweight and lowers the price target from $551 to $496.